Overview on Drug Quality and Drug Standard Sompol Prakongpan, Ph.D. Faculty of Pharmacy, Mahidol University 26 March 2010.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

WHO Good Distribution Practices for Pharmaceutical Products
Biopharmaceutical Quality
Drug and Therapeutics Committee Session 5. Pharmaceutical Quality Assurance.
Producing a Pharmaceutical or Biopharmaceutical
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
Chemistry, Manufacturing, and Controls (CMC) and Good Manufacturing Practices (GMPs): The Big Picture of a Long-term Commitment Elizabeth Pollina Cormier,
BRC Storage & Distribution Safety and Quality Management System Training Guide
The concept of Quality ● Quality means those features of products which meet customers needs and thereby provide customer satisfaction. This meaning is.
Good hygienic practices
Quality control of raw materials In-process control
Good Manufacturing Practices and Quality Control
IF IT WAS NOT DOCUMENTED, THEN IT WAS NOT DONE”
Good Manufacturing Practices Purpose and Principles of GMP
World Health Organization
By: Muhammad Naeem Quality Assurance and Regulatory Manager
Good Manufacturing Practices for Blood Establishments
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Codex Guidelines for the Application of HACCP
SQF ISO FSSC GMP Programs
World Health Organization
Current Good Manufacturing Practices (cGMP’s). Biotechnology using living cells and materials produced by cells to create pharmaceutical, diagnostic,
Regulatory Overview.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Module 5Slide 1 of 24 WHO - EDM Part One, Sections 6 and 7 Basic Principles of GMP Complaints and Recalls.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
World Health Organization
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
Quality Control Approaches for Essential Medicines “Good Intentions – Bad Drugs” The World Bank March 10, 2005.
Important informations
ACCESS TO MEDICINES - POLICY AND ISSUES
Compounding Kenneth Schell Pharm. D President, CA State Board of Pharmacy.
Expectations for Facilities & cGMPs Biological Response Modifiers Advisory Committee Meeting October 9, 2003 Nicholas Obiri, Ph.D. CBER.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
Basic Principles of GMP
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:
Producing a Pharmaceutical or Biopharmaceutical The Manufacturing Process.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
GMP AND cGMP CONSIDERATIONS
Quality Control significance in pharmaceutical industry
Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines are manufactured.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Author: Nurul Azyyati Sabri
Author: Nurul Azyyati Sabri
Good Manufacturing Practice
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Quality Control and Assurance
April 12, 09 A. Saffari, PH.D Former WHO Technical Officer
Drug and Therapeutics Committee
Nonsterile compounding-USP ch 795
QUALITY ASSURANCE AND QUALITY CONTROL IN GENERICS
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Quality Assurance and Quality Control in Generics
QUALITY ASSURANCE OF PHARMACEUTICAL PRODUCTS IN RMH
GOOD MANUFACTURING PRACTICE(GMP): AN OVERVIEW By- Dr. Jill Shukla
PHARMACEUTICAL QUALITY
Food Production Systems
Nonsterile compounding-USP ch 795
Good Manufacturing Practices GMP ممارسات التصنيع الجيد
Introduction to GMP.
Nonsterile compounding-USP ch 795
Producing a Pharmaceutical or Biopharmaceutical
SQF ISO FSSC GMP Programs
Compounded Drugs and Lack of Premarket FDA-Approval
Storage and distribution
Presentation transcript:

Overview on Drug Quality and Drug Standard Sompol Prakongpan, Ph.D. Faculty of Pharmacy, Mahidol University 26 March 2010

Medicine Quality Desired characteristics of product to ensure : Safety Efficacy Quality

Number of Drug-Quality Reports Received by the FDA, 1999–2007

Background : 236 Children died in Bangladesh : 40 Children died in Nigeria diethylene glycol : 88 Children died in Haiti : 116 died in Panama : 24 died in Bangladesh Paracetamol elixir, Cough syrup: Glycerol adulterated with diethylene glycol.

USP and Glycerin   Glycerin revision (official May 1, 2009) includes a Limit test for both Diethylene Glycol (DEG) and Ethylene Glycol (EG) at 0.10% each in the Identification test   Official monograph and reference standard information posted on the USPC website:

Types of Quality Problems mislabeled drugs inaccurate or unreadable product labels/labeling sterile containers or vials that are punctured or leaking packaging or product mix-ups abnormal odor or taste capsule leakage

Types of Quality Problems (Cont.) chipped, cracked, or splitting tablets tablet or capsule discolorations broken, cracked, or chipped syringes suspected product contamination vials with foreign floating objects or growth container closure defects leaking vials

Metal fragment

Impacts of Low-Quality Medicines ?MEDICINEQUALITY  Materials  Manufacturing process  Packaging  Transportation  Storage condition  Lack of therapeutic effect Prolonged illness Death  Toxic and adverse reaction  Waste of limited financial resources  Loss of credibility

Determinants of Medicine Quality  Identity: Active ingredient  Purity: Not contaminated with potentially harmful substances  Potency: Usually 90–110% of the labeled amount  Uniformity: Consistency of color, shape, size  Other Specifications: polymorph, particle size, chirality, dissolution,  Bioavailability: Interchangeable products?  Stability: Ensuring medicine activity for stated period Identity, purity, potency, uniformity are defined in pharmacopoeias and stated in certificate of analysis (COA)

Why is a Public Standard Important?   Assure a consistent approach to quality for pioneer and generic products   Assess the quality of drug products in commerce   Provide specifications that new manufacturers can target   Monitor for counterfeit and substandard products   Monitor the quality of imported drug products   Provide information for compounding pharmacists

Thai Pharmacopoeia New generics : major consumption Difference in standard and testing methods among official pharmacopoeias Thai formulary, herb Biopharmaceuticals? Insulin, somatropin, interferon

How is quality Assured? Quality Assurance (QA): The sum total of all arrangements made with the object of ensuring that medicinal products are of the quality required for their intended use.

Quality Chain Operation Good Practices (GxP) R & D GCP FormulationGFP RegistrationGRP ManufacturingGMP/GLP StorageGSP DistributionGDP DispensingGPP Consumers Proper use

Definitions (Continued…) Good Manufacturing Practice (GMP) GMP is that part of quality assurance which ensures that products are consistency produced and controlled to the quality, standard required for their intended use.

Basic Principle of GMP 1. Quality, safety and efficacy must be designed and built in the product. 2. Testing alone cannot be relied on to ensure quality. 3. Each step in the manufacturing process must be controlled to ensure that the final product within limits and specifications.

Basic Requirements for GMP Clearly defined and systematically reviewed processes. Critical steps validated. Appropriate resources: personnel, buildings, equipment, materials. Clearly written procedures. Trained operators. Complete records, failure investigations. Recall system. Complaint handling.

Why GMP compliance important? GMP aim to ensure that the product is made in a way that : Assure consistency of quality, batch-after- batch. Ensure that any change is only implemented after impact on quality is assessed. Ensure that record keeping ensure traceability of all action and therefore, verification of complaints.

Absence of GMP means: Batch-to-batch quality consistency is not assured. Changes may be implemented without consideration for impact on quality. Deficient record keeping make investigation impossible. Contamination by other products from poorly cleaned multipurpose equipments. Different purity, strength, efficiency, safety and quality. Production operation different from the filing at the authority. Poor control and traceability of production.

GMP compliance is expensive as GMP requires: Higher standard of facilities. Critical changes to procedure, equipment, raw material require validation Stability testing Bioequivalence Qualified staff.

Business impact: More cost Reduce speed Reduce flexibility GMP is very expensive Hence much temptation to forget GMP and take short-cuts. This can be eliminated by regulate INSPECTION.

GDP – Good Distribution Practices Organization and management Personnel Quality management Premises, warehousing and storage Vehicles and equipment Shipment containers and container labelling Distribution Transportation and products in transit

What are GPP’s? (Good Pharmacy Practices) Framework for standards to suit national situation and needs for pharmacy practice Goal to provide consistent, quality, pharmacy services Other Tools: – Pharmacist and Other Healthcare Provider Good Practice Guidelines for the detection and prevention of Counterfeit Drugs – Partnership for Safe Medicines

Pharmacovigilance Systems Relates to the detection, assessment, understanding and prevention of adverse effects of medical products – Reports from manufacturers, healthcare providers, and patients on the adverse effects Purpose: identifying new information about hazards associated with medicines preventing harm to patients

Who Ensures Medicine Quality?  Drug regulatory authority  Drug Therapeutics Therapeutics Committee Committee  Hospital procurement procurement office office  Patients  Physicians and other and other prescribers prescribers  Pharmacy (and dispensers) (and dispensers) MedicineQuality

Quality Assessment COA – –Identity, purity, potency, uniformity –Additional test: dissolution test, polymorph, particulate matter, bacterial endotoxin test Company track record: responsibility, recall, defect, service GMP/PICs Raw materials: active, inactive ingredients, impurity, etc

Thank You